FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083670498> ?p ?o ?g. }

• W2083670498 endingPage "1080" @default.
• W2083670498 startingPage "1074" @default.
• W2083670498 abstract "Advances in antiemetic therapy for chemotherapy-induced emesis have resulted in improved protection against symptoms occurring within 24 h of chemotherapy. However, the vomiting which tends to occur beyond 24 h after chemotherapy (delayed-phase vomiting) is still relatively poorly controlled by the currently available drugs, suggesting that more than one mechanism may mediate these symptoms. The standard antiemetic regimen currently recommended for prevention of chemotherapy-induced emesis includes a serotonin (5-HT(3)) antagonist and a corticosteroid. The neurokinin-1 (NK(1)) antagonist aprepitant represents a new class of antiemetic currently in clinical development. Using data obtained in 2 Phase II clinical trials of aprepitant in patients receiving chemotherapy based on the highly emetogenic chemotherapeutic agent cisplatin, we compared the time course of antiemetic effect of aprepitant, a 5-HT(3) antagonist, or a combination of both. Over the entire observation period (up to 7 days post-cisplatin), patients who received the NK(1) antagonist had a superior prevention of emesis. However, in the first 24 h after cisplatin, emesis occurred in fewer patients who received the 5-HT(3) antagonist than in patients who did not receive this class of drug. Furthermore, the majority of treatment failures in patients who received the NK(1) antagonist occurred within the first 8-12 h of chemotherapy, whereas the treatment failures in patients who received a 5-HT(3) antagonist were more evenly distributed over time. Patients who received both drugs had superior control of symptoms compared with patients who received one or the other. The difference in the time course of emesis blockade observed with two different classes of receptor antagonists provides substantial evidence for involvement of separate pathophysiological mechanisms in chemotherapy-induced vomiting. Serotonin mediates the early vomiting process that occurs within 8-12 h following cisplatin-based chemotherapy, after which time substance P acting at NK(1) receptors becomes the dominant mediator of vomiting" @default.
• W2083670498 created "2016-06-24" @default.
• W2083670498 creator A5002264412 @default.
• W2083670498 creator A5015616162 @default.
• W2083670498 creator A5026257303 @default.
• W2083670498 creator A5028379207 @default.
• W2083670498 creator A5033285318 @default.
• W2083670498 creator A5036115757 @default.
• W2083670498 creator A5037398995 @default.
• W2083670498 creator A5061133224 @default.
• W2083670498 creator A5069041063 @default.
• W2083670498 date "2003-05-01" @default.
• W2083670498 modified "2023-10-03" @default.
• W2083670498 title "Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists" @default.
• W2083670498 cites W1530830778 @default.
• W2083670498 cites W1881601848 @default.
• W2083670498 cites W1963685566 @default.
• W2083670498 cites W1970239727 @default.
• W2083670498 cites W1973166256 @default.
• W2083670498 cites W1975033059 @default.
• W2083670498 cites W1975639439 @default.
• W2083670498 cites W1976557660 @default.
• W2083670498 cites W1983413945 @default.
• W2083670498 cites W1983794140 @default.
• W2083670498 cites W1985260719 @default.
• W2083670498 cites W1986564836 @default.
• W2083670498 cites W1996898160 @default.
• W2083670498 cites W2001859143 @default.
• W2083670498 cites W2007836005 @default.
• W2083670498 cites W2021465015 @default.
• W2083670498 cites W2031786331 @default.
• W2083670498 cites W2038974566 @default.
• W2083670498 cites W2042142736 @default.
• W2083670498 cites W2067747375 @default.
• W2083670498 cites W2074100969 @default.
• W2083670498 cites W2074904040 @default.
• W2083670498 cites W2076435979 @default.
• W2083670498 cites W2077054055 @default.
• W2083670498 cites W2086504064 @default.
• W2083670498 cites W2119544301 @default.
• W2083670498 cites W2128040637 @default.
• W2083670498 cites W2160465588 @default.
• W2083670498 cites W2324983656 @default.
• W2083670498 cites W2338394838 @default.
• W2083670498 cites W65549807 @default.
• W2083670498 doi "https://doi.org/10.1016/s0959-8049(02)00674-3" @default.
• W2083670498 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12736106" @default.
• W2083670498 hasPublicationYear "2003" @default.
• W2083670498 type Work @default.
• W2083670498 sameAs 2083670498 @default.
• W2083670498 citedByCount "225" @default.
• W2083670498 countsByYear W20836704982012 @default.
• W2083670498 countsByYear W20836704982013 @default.
• W2083670498 countsByYear W20836704982014 @default.
• W2083670498 countsByYear W20836704982015 @default.
• W2083670498 countsByYear W20836704982016 @default.
• W2083670498 countsByYear W20836704982017 @default.
• W2083670498 countsByYear W20836704982018 @default.
• W2083670498 countsByYear W20836704982019 @default.
• W2083670498 countsByYear W20836704982020 @default.
• W2083670498 countsByYear W20836704982021 @default.
• W2083670498 countsByYear W20836704982022 @default.
• W2083670498 countsByYear W20836704982023 @default.
• W2083670498 crossrefType "journal-article" @default.
• W2083670498 hasAuthorship W2083670498A5002264412 @default.
• W2083670498 hasAuthorship W2083670498A5015616162 @default.
• W2083670498 hasAuthorship W2083670498A5026257303 @default.
• W2083670498 hasAuthorship W2083670498A5028379207 @default.
• W2083670498 hasAuthorship W2083670498A5033285318 @default.
• W2083670498 hasAuthorship W2083670498A5036115757 @default.
• W2083670498 hasAuthorship W2083670498A5037398995 @default.
• W2083670498 hasAuthorship W2083670498A5061133224 @default.
• W2083670498 hasAuthorship W2083670498A5069041063 @default.
• W2083670498 hasConcept C118303440 @default.
• W2083670498 hasConcept C126322002 @default.
• W2083670498 hasConcept C170493617 @default.
• W2083670498 hasConcept C202871150 @default.
• W2083670498 hasConcept C2776533618 @default.
• W2083670498 hasConcept C2776694085 @default.
• W2083670498 hasConcept C2776885963 @default.
• W2083670498 hasConcept C2780574406 @default.
• W2083670498 hasConcept C2780852908 @default.
• W2083670498 hasConcept C2780884295 @default.
• W2083670498 hasConcept C2781413609 @default.
• W2083670498 hasConcept C42219234 @default.
• W2083670498 hasConcept C71924100 @default.
• W2083670498 hasConcept C98274493 @default.
• W2083670498 hasConceptScore W2083670498C118303440 @default.
• W2083670498 hasConceptScore W2083670498C126322002 @default.
• W2083670498 hasConceptScore W2083670498C170493617 @default.
• W2083670498 hasConceptScore W2083670498C202871150 @default.
• W2083670498 hasConceptScore W2083670498C2776533618 @default.
• W2083670498 hasConceptScore W2083670498C2776694085 @default.
• W2083670498 hasConceptScore W2083670498C2776885963 @default.
• W2083670498 hasConceptScore W2083670498C2780574406 @default.
• W2083670498 hasConceptScore W2083670498C2780852908 @default.
• W2083670498 hasConceptScore W2083670498C2780884295 @default.
• W2083670498 hasConceptScore W2083670498C2781413609 @default.

• next